Dr. Priyabrata Pattnaik, profile picture

Dr. Priyabrata Pattnaik

Sort by
Virus Safety in Vaccine Production
Development of Production and Purification Platformform for Influenza Vaccine
Production and purification of Viral vectors for gene and cell therapy applications
Development of a production and purification platform for VLP vaccine candidates
Production and Purification of Virus Like Particle (VLP) based Vaccine
Process development considerations for quality and safety of vaccines
Strategic Considerations for Implementing Single-Use Technologies in Vaccine Process
Pandemic Vaccine Supply - Challenges & Opportunities: A Raw Materials Perspective
Accelerating vaccine development and manufacturing
Merck Millipore holds vaccine technology seminar in South Korea
Overcoming challenges of host cell DNA removal in vaccine manufacturing
Best Practices in Nucleic Acid Removal from Vaccine Processes
Pragmatic implementation of single use technologies to deliver clinical supply
Viral-vectored vaccines: a new approach in the vaccine manufacturing process